Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Research Summary

Biography

I was born in 1966 and performed my undergraduate and graduate studies in Biochemistry at the University of Oxford in Merton College. I graduated with First Class Honours, winning the Gibb’s Prize for joint top-First, and was Senior Scholar at Merton during my DPhil (=PhD). I held a post-doctoral position at Harvard Medical School (Martinos Imaging Centre) before returning to the UK in 1996 to help found and establish the FMRIB Centre. In 2001, I was tenured and appointed to a University Lectureship with tutorial fellowship at Christ Church at the University of Oxford. I became the Director of the FMRIB Centre in 2005 and Professor of Pain Research. In 2007 while remaining as FMRIB Director, I was elected to the Chair in Anaesthetics with Fellowship at Pembroke College. I was an elected Councillor to the International Association for the Study of Pain (IASP) until 2014 and was Chair of their Scientific Program Committee for the Milan 2012 biannual world congress. In 2008, I was awarded the triennial Patrick Wall Medal from the Royal College of Anaesthetists and in 2009 was made a FRCA for my contributions to the discipline. I was Deputy Chair of the UK’s Medical Research Council’s Neuroscience Mental Health Board for two years and board member from 2009-2014. I was a REF panel member for Neuroscience, Psychiatry and Psychology in 2014. In 2015, I was elected a Fellow of the Academy of Medical Sciences. After ten years Directing the FMRIB Centre, I handed over the Directorship in May 2015 to Professor Heidi Johansen-Berg in order to take a one-year sabbatical and focus on other challenges.

I am married to Professor Myles Allen, a climate physicist, and we have three wonderful yet irrepressible children: a daughter, Colette, and two sons, John and Jim.

Awards Training and Qualifications

  • 19851989 BA, Biochemistry, 1st ClassUniversity of Oxford
  • 19901993 DPhil (PhD), University of Oxford
  • 2009 FRCA, Royal College of Anaesthetists
  • 2015 FMedSci, Fellow Academy of Medical Sciences

Recent Publications

5 View 225 more »

Irene Tracey


Nuffield Professor of Anaesthetic Science

  • Head of Nuffield Division Anaesthetics and Associate Head of Medical Sciences Division (Personnel)

Recent Publications

5 View 225 more »
Biography

Research Summary

The ability to experience pain is old and shared across species. It is our warning 'harm alarm' system and, as such, feeling pain confers an evolutionary advantage. However, when it becomes chronic, as it does in approximately 20% of the adult population, it causes significant suffering and major cost implications for society (www.painineurope.com and http://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx). As such, pain is no longer advantageous and ruins lives. The definition of pain is: “An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage” – International Association for the Study of Pain (IASP Taxonomy – http://www.iasp-pain.org/Taxonomy). The FMRIB Pain Analgesia-Anaesthesia Imaging Neuroscience (P.A.I.N) Group, which I head, aims to understand pain perception, analgesia and altered states of consciousness through advanced neuroimaging. For further information, see http://www.ndcn.ox.ac.uk/research/fmrib-pain-group

The FMRIB Centre is recognised as one of the world’s leading neuroimaging laboratories that integrates research into key neurological and neuroscientific problems with cutting-edge developments in MR physics and data analysis (http://www.fmrib.ox.ac.uk). The Centre has approximately 110 scientists and clinicians from a range of backgrounds and I was their Director for ten years until May 2015.

Sources of Funding

  • The Medical Research Council
  • The Wellcome Trust
  • The Innovative Medicines Initiative (Europain)
  • NIHR Oxford Biomedical Research Centre
  • ABIDE Therapeutics
  • Grünthenthal GmbH. 
  • Former financial support from many other organisations is recognized in the acknowledgment section of our published papers.